NIH Establishes Monkey Model for MERS-CoV

An NIH study suggests that marmoset models are the optimum option for testing new drugs for MERS Scientists from the National Institutes of Health have found that the Middle East Respiratory (MERS) virus in marmosets provokes a very similar response to humans afflicted with MERS caused pneumonia. The doctors began testing MERS treatments on marmosets after using computer models to …

Mers-CoV ‘On Course’ According to the Published Genomic Replikin Count Predictions of 2012 and 2013

Comparison with the Replikins Counts and Course of the SARS Outbreak of 2003 and the H1N1 Pandemic of 2009 Completed in 4 days, First Batch of 20,000 doses of Freeze-Dried Solid Phase Synthetic Anti-Mers-CoV Vaccine Is Ready for Testing Today April 30, 2014 Bioradar UK Ltd. and Replikins Ltd. announced today that the clinical course of the current Mers-CoV outbreak …